Praxis Precision Medicines, Inc.
PRAX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $1 | $1 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | -100% | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | -654.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | -856.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | -786.3% |
| EPS Diluted | -3.36 | -3.31 | -3.29 | -2.94 |
| % Growth | -1.5% | -0.6% | -11.9% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |